Precision antimicrobials aim to kill pathogens without damaging commensal bacteria in the host, and thereby cure disease without antibiotic-associated dysbiosis. Here we report the de novo design of a synthetic host defence peptide that targets a specific pathogen by mimicking key molecular features of the pathogen’s channel-forming membrane proteins. By exploiting physical and structural vulnerabilities within the pathogen’s cellular envelope, we designed a peptide sequence that undergoes instructed tryptophan-zippered assembly within the mycolic acid-rich outer membrane of Mycobacterium tuberculosis to specifically kill the pathogen without collateral toxicity towards lung commensal bacteria or host tissue. These mycomembrane-templated assemblies elicit rapid mycobactericidal activity and enhance the potency of antibiotics by improving their otherwise poor diffusion across the rigid M. tuberculosis envelope with respect to agents that exploit transmembrane protein channels for antimycobacterial activity. This biomimetic strategy may aid the design of other narrow-spectrum antimicrobial peptides.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
The main data supporting the results in this study are available within the paper and its Supplementary Information. The raw and analysed datasets generated during the study are too large to be publicly shared, but they are available for research purposes from the corresponding author on reasonable request.
The parallelized DMD simulation engine (πDMD, v.1.0) with Medusa all-atom force field is available from Molecules In Action (http://moleculesinaction.com). The software is available for free to academic users.
Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544–545 (2016).
Brito, I. L. et al. Mobile genes in the human microbiome are structured from global to individual scales. Nature 535, 435–439 (2016).
Smillie, C. S. et al. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480, 241–244 (2011).
Levy, M., Blacher, E. & Elinav, E. Microbiome, metabolites and host immunity. Curr. Opin. Microbiol. 35, 8–15 (2017).
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A. & Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol. 17, 219–232 (2017).
Spellberg, B. & Rex, J. H. The value of single-pathogen antibacterial agents. Nat. Rev. Drug Discov. 12, 963–963 (2013).
Lewis, K. Recover the lost art of drug discovery. Nature 485, 439–440 (2012).
Maxson, T. & Mitchell, D. A. Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics. Tetrahedron 72, 3609–3624 (2016).
Brown, E. D. & Wright, G. D. Antibacterial drug discovery in the resistance era. Nature 529, 336–343 (2016).
Melander, R. J., Zurawski, D. V. & Melander, C. Narrow-spectrum antibacterial agents. Medchemcomm 9, 12–21 (2018).
Niederweis, M. Mycobacterial porins—new channel proteins in unique outer membranes. Mol. Microbiol. 49, 1167–1177 (2003).
Mahfoud, M., Sukumaran, S., Hülsmann, P., Grieger, K. & Niederweis, M. Topology of the porin MspA in the outer membrane of Mycobacterium smegmatis. J. Biol. Chem. 281, 5908–5915 (2006).
Alderwick, L. J., Harrison, J., Lloyd, G. S. & Birch, H. L. The mycobacterial cell wall—peptidoglycan and arabinogalactan. Cold Spring Harb. Perspect. Med. 5, a021113 (2015).
Tossi, A., Sandri, L. & Giangaspero, A. Amphipathic, α‐helical antimicrobial peptides. Pept. Sci. 55, 4–30 (2000).
Huang, Y., Huang, J. & Chen, Y. Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell 1, 143–152 (2010).
Sharpe, H. J., Stevens, T. J. & Munro, S. A comprehensive comparison of transmembrane domains reveals organelle-specific properties. Cell 142, 158–169 (2010).
Wang, Q. et al. PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis. Science 367, 1147–1151 (2020).
Melly, G. & Purdy, G. E. MmpL proteins in physiology and pathogenesis of M. tuberculosis. Microorganisms 7, 70 (2019).
Vandal, O. H., Pierini, L. M., Schnappinger, D., Nathan, C. F. & Ehrt, S. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat. Med. 14, 849–854 (2008).
Vergne, I. et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 102, 4033–4038 (2005).
Deretic, V. et al. Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell. Microbiol. 8, 719–727 (2006).
Cochran, A. G., Skelton, N. J. & Starovasnik, M. A. Tryptophan zippers: stable, monomeric β-hairpins. Proc. Natl Acad. Sci. USA 98, 5578–5583 (2001).
Liu, J., Yong, W., Deng, Y., Kallenbach, N. R. & Lu, M. Atomic structure of a tryptophan-zipper pentamer. Proc. Natl Acad. Sci. USA 101, 16156–16161 (2004).
Heinz, C., Karosi, S. & Niederweis, M. High-level expression of the mycobacterial porin MspA in Escherichia coli and purification of the recombinant protein. J. Chromatogr. B 790, 337–348 (2003).
Ragazzon, G. & Prins, L. J. Energy consumption in chemical fuel-driven self-assembly. Nat. Nanotechnol. 13, 882–889 (2018).
Lin, Y. et al. Residue-specific solvation-directed thermodynamic and kinetic control over peptide self-assembly with 1D/2D structure selection. ACS Nano 13, 1900–1909 (2019).
Vandal, O. H., Nathan, C. F. & Ehrt, S. Acid resistance in Mycobacterium tuberculosis. J. Bacteriol. 191, 4714–4721 (2009).
The European Committee on Antimicrobial Susceptibility Testing Clinical Breakpoints and Dosing Version 8.1 (European Society of Clinical Microbiology and Infectious Diseases, 2018).
Ramón-García, S. et al. Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. Antimicrob. Agents Chemother. 57, 2295–2303 (2013).
Brown, L., Wolf, J. M., Prados-Rosales, R. & Casadevall, A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat. Rev. Microbiol. 13, 620–630 (2015).
Maitra, A. et al. Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles’ heel for the TB-causing pathogen. FEMS Microbiol. Rev. 43, 548–575 (2019).
Muheim, C. et al. Increasing the permeability of Escherichia coli using MAC13243. Sci. Rep. 7, 17629 (2017).
Helander, I. & Mattila‐Sandholm, T. Fluorometric assessment of Gram‐negative bacterial permeabilization. J. Appl. Microbiol. 88, 213–219 (2000).
Eriksson, M., Nielsen, P. E. & Good, L. Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J. Biol. Chem. 277, 7144–7147 (2002).
Halder, S. et al. Alteration of Zeta potential and membrane permeability in bacteria: a study with cationic agents. Springerplus 4, 672–672 (2015).
Yavvari, P. S. et al. Clathrin-independent killing of intracellular mycobacteria and biofilm disruptions using synthetic antimicrobial polymers. Biomacromolecules 18, 2024–2033 (2017).
Butler, D., Goel, N., Goodnight, L., Tadigadapa, S. & Ebrahimi, A. Detection of bacterial metabolism in lag-phase using impedance spectroscopy of agar-integrated 3D microelectrodes. Biosens. Bioelectron. 129, 269–276 (2019).
Bolotsky, A. et al. Two-dimensional materials in biosensing and healthcare: from in vitro diagnostics to optogenetics and beyond. ACS Nano 13, 9781–9810 (2019).
Inoue, S. et al. Dielectrophoretic characterization of antibiotic-treated Mycobacterium tuberculosis complex cells. Anal. Bioanal. Chem. 407, 7673–7680 (2015).
Perera, A. S., Wang, H., Shrestha, T. B., Troyer, D. L. & Bossmann, S. H. Nanoscopic surfactant behavior of the porin MspA in aqueous media. Beilstein J. Nanotechnol. 4, 278–284 (2013).
Hu, B. et al. Polyphenol-binding amyloid fibrils self-assemble into reversible hydrogels with antibacterial activity. ACS Nano 12, 3385–3396 (2018).
Torrent, M., Pulido, D., Nogués, M. V. & Boix, E. Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation. PLoS Pathog. 8, e1003005 (2012).
Truant, J., Brett, W. & Thomas, W. Jr Fluorescence microscopy of tubercle bacilli stained with auramine and rhodamine. Henry Ford. Hosp. Med. J. 10, 287–296 (1962).
Danilchanka, O., Pavlenok, M. & Niederweis, M. Role of porins for uptake of antibiotics by Mycobacterium smegmatis. Antimicrob. Agents Chemother. 52, 3127–3134 (2008).
Chairatana, P. & Nolan, E. M. Molecular basis for self-assembly of a human host-defense peptide that entraps bacterial pathogens. J. Am. Chem. Soc. 136, 13267–13276 (2014).
Chairatana, P. & Nolan, E. M. Human α-defensin 6: a small peptide that self-assembles and protects the host by entangling microbes. Acc. Chem. Res. 50, 960–967 (2017).
Schroeder, B. et al. Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide. Mucosal Immunol. 8, 661–671 (2015).
Vetterli, S. U. et al. Thanatin targets the intermembrane protein complex required for lipopolysaccharide transport in Escherichia coli. Sci. Adv. 4, eaau2634 (2018).
Robinson, J. A. Folded synthetic peptides and other molecules targeting outer membrane protein complexes in Gram-negative bacteria. Front Chem. 7, 45–45 (2019).
Luther, A. et al. Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576, 452–458 (2019).
Levitt, M. Conformational preferences of amino acids in globular proteins. Biochemistry 17, 4277–4285 (1978).
Gehman, J. D. et al. Effect of antimicrobial peptides from Australian tree frogs on anionic phospholipid membranes. Biochemistry 47, 8557–8565 (2008).
Jiang, Z. et al. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α-helical cationic antimicrobial peptides. Biopolymers 90, 369–383 (2008).
Mikut, R. et al. Improving short antimicrobial peptides despite elusive rules for activity. Biochim. Biophys. Acta, Biomembr. 1858, 1024–1033 (2016).
Rekdal, Ø. et al. Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity. J. Biol. Chem. 287, 233–244 (2012).
Medina, S. H. et al. An intrinsically disordered peptide facilitates non-endosomal cell entry. Angew. Chem. Int. Ed. 55, 3369–3372 (2016).
Rath, P. et al. Cord factor (trehalose 6,6′-dimycolate) forms fully stable and non-permeable lipid bilayers required for a functional outer membrane. Biochim. Biophys. Acta, Rev. Biomembr. 1828, 2173–2181 (2013).
Epand, R. F., Savage, P. B. & Epand, R. M. Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (ceragenins). Biochim. Biophys. Acta Biomembr. 1768, 2500–2509 (2007).
Lombardi, L. et al. Antimicrobial peptides at work: interaction of myxinidin and its mutant WMR with lipid bilayers mimicking the P. aeruginosa and E. coli membranes. Sci. Rep. 7, 44425–44425 (2017).
Zehethofer, N. et al. Lipid analysis of airway epithelial cells for studying respiratory diseases. Chromatographia 78, 403–413 (2015).
Andrews, J. M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48, 5–16 (2001).
Zhang, Y., Zhang, H. & Sun, Z. Susceptibility of Mycobacterium tuberculosis to weak acids. J. Antimicrob. Chemother. 52, 56–60 (2003).
Avitabile, C., D’Andrea, L. D. & Romanelli, A. Circular dichroism studies on the interactions of antimicrobial peptides with bacterial cells. Sci. Rep. 4, 4293–4293 (2014).
Tao, L. et al. Probing the amyloid peptide–membrane interaction using a liposome model system. J. Self-Assem. Mol. Electron. 4, 1–18 (2016).
Dokholyan, N. V., Buldyrev, S. V., Stanley, H. E. & Shakhnovich, E. I. Discrete molecular dynamics studies of the folding of a protein-like model. Fold. Des. 3, 577–587 (1998).
Proctor, E. A., Ding, F. & Dokholyan, N. V. Discrete molecular dynamics. WIREs Comput. Mol. Sci. 1, 80–92 (2011).
Ding, F., Tsao, D., Nie, H. & Dokholyan, N. V. Ab initio folding of proteins with all-atom discrete molecular dynamics. Structure 16, 1010–1018 (2008).
Ding, F. & Dokholyan, N. V. Emergence of protein fold families through rational design. PLoS Comput. Biol. 2, e85 (2006).
Lazaridis, T. & Karplus, M. Effective energy function for proteins in solution. Proteins Struct. Funct. Bioinf. 35, 133–152 (1999).
Ding, F., Borreguero, J. M., Buldyrey, S. V., Stanley, H. E. & Dokholyan, N. V. Mechanism for the α‐helix to β‐hairpin transition. Proteins Struct. Funct. Bioinf. 53, 220–228 (2003).
Sugita, Y. & Okamoto, Y. Replica-exchange molecular dynamics method for protein folding. Chem. Phys. Lett. 314, 141–151 (1999).
Okamoto, Y. Generalized-ensemble algorithms: enhanced sampling techniques for Monte Carlo and molecular dynamics simulations. J. Mol. Graph. Model. 22, 425–439 (2004).
Feig, M., Karanicolas, J. & Brooks, C. L. III MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. J. Mol. Graph. Model. 22, 377–395 (2004).
Kumar, S., Rosenberg, J. M., Bouzida, D., Swendsen, R. H. & Kollman, P. A. The weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method. J. Comput. Chem. 13, 1011–1021 (1992).
Barton, G. OC-A cluster analysis program (Univ. of Dundee, 2002).
Coyne, J., Davis, B., Kauffman, D., Zhao, N. & Wang, Y. Polymer microneedle mediated local aptamer delivery for blocking the function of vascular endothelial growth factor. ACS Biomater. Sci. Eng. 3, 3395–3403 (2017).
Burch, J. M., Mashayekh, S., Wykoff, D. D. & Grimes, C. L. Bacterial derived carbohydrates bind Cyr1 and trigger hyphal growth in Candida albicans. ACS Infect. Dis. 4, 53–58 (2018).
Date, T., Sekine, J., Matsuno, H. & Serizawa, T. Polymer-binding peptides for the noncovalent modification of polymer surfaces: effects of peptide density on the subsequent immobilization of functional proteins. ACS Appl. Mater. Interfaces 3, 351–359 (2011).
Sudji, I. R., Subburaj, Y., Frenkel, N., García-Sáez, A. J. & Wink, M. Membrane disintegration caused by the steroid saponin digitonin is related to the presence of cholesterol. Molecules 20, 20146–20160 (2015).
Bishop, J. G., Schanbacher, F., Ferguson, L. C. & Smith, K. L. In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferin. Infect. Immun. 14, 911–918 (1976).
Xie, Z. et al. Immune cell-mediated biodegradable theranostic nanoparticles for melanoma targeting and drug delivery. Small 13, 1603121 (2017).
Singh, B., Saqib, M., Gupta, A., Kumar, P. & Bhaskar, S. Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages. PLoS ONE 12, e0189606 (2017).
Iyoda, T. et al. A novel mechanism underlying the basic defensive response of macrophages against Mycobacterium infection. J. Immunol. 192, 4254–4262 (2014).
Jo, S. H. et al. Calreticulin modulates the intracellular survival of mycobacteria by regulating ER-stress-mediated apoptosis. Oncotarget 8, 58686 (2017).
Xu, X. et al. Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance. Sci. Rep. 8, 7237 (2018).
We thank the Penn State Microscopy and Cytometry Facility, University Park, PA for assistance with confocal and electron microscopy; the Penn State X-Ray Crystallography Facility, University Park, PA for use of the CD spectrophotometer; the Penn State NMR Facility, University Park, PA for use of NMR instrumentation. Funding for this research was provided by the Penn State Institute of Energy and the Environment Human Health and the Environment Seed Grant awarded to S.H.M. This work was also supported by NIH grant number AI123146 to A.D.B. A.W.S. was supported by funds from the Penn State Graduate Research Fellowship.
The authors declare no competing interests.
Peer review information Nature Biomedical Engineering thanks Stephan Sieber and the other, anonymous, reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Simonson, A.W., Mongia, A.S., Aronson, M.R. et al. Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry. Nat Biomed Eng 5, 467–480 (2021). https://doi.org/10.1038/s41551-020-00665-x